000144748 001__ 144748
000144748 005__ 20240229123020.0
000144748 020__ $$a978-1-4939-9793-0 (print)
000144748 020__ $$a978-1-4939-9794-7 (electronic)
000144748 0247_ $$2doi$$a10.1007/978-1-4939-9794-7_20
000144748 0247_ $$2pmid$$apmid:31486047
000144748 0247_ $$2ISSN$$a1064-3745
000144748 0247_ $$2ISSN$$a1940-6029
000144748 0247_ $$2altmetric$$aaltmetric:65992280
000144748 037__ $$aDKFZ-2019-02180
000144748 041__ $$aeng
000144748 082__ $$a570
000144748 1001_ $$0P:(DE-HGF)0$$aKiprianova, Irina$$b0$$eFirst author
000144748 245__ $$aFluorescence In Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-Treated Human Brain Tumors.
000144748 260__ $$a[Heidelberg]$$b[Springer]$$c2020
000144748 3367_ $$2DRIVER$$aarticle
000144748 3367_ $$2DataCite$$aOutput Types/Journal article
000144748 3367_ $$0PUB:(DE-HGF)3$$2PUB:(DE-HGF)$$aBook$$mbook
000144748 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601379981_28064
000144748 3367_ $$2BibTeX$$aARTICLE
000144748 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144748 3367_ $$00$$2EndNote$$aJournal Article
000144748 500__ $$a#EA:F010#LA:F010#
000144748 520__ $$aFluorescence in situ hybridization (FISH) is a specific, sensitive, accurate, and reliable technique widely applied in both research and clinic. Here we describe the detailed protocol of a FISH method established by us to serve the scientific purposes of the first oncolytic parvovirus clinical trial (ParvOryx01). This trial was launched in Germany in 2011. After trial completion in 2015, results were published in Molecular Therapy in 2017. The primary purpose of the trial was to evaluate the safety of an oncolytic parvovirus, H-1PV (ParvOryx), in recurrent glioblastoma patients. In addition, the efficiency of H-1PV tumor targeting after intratumoral or systemic virus administration was assessed by FISH detection of viral nucleic acids (genomic single-stranded DNA, mRNA and parvovirus double-stranded replicative forms) in formalin-fixed paraffin-embedded glioblastoma tissues resected at day 10 after ParvOryx treatment. The FISH method allowed the detection-for the first time in humans-of H-1PV replication markers in brain tumors of parvovirus-treated patients. A protocol combining mRNA FISH with simultaneous immunofluorescent staining for tumor and tumor microenvironment markers was also developed and is described here, in order to better characterize H-1PV cellular targets and H-1PV treatment-associated tumor microenvironment changes.
000144748 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000144748 588__ $$aDataset connected to CrossRef Book Series, PubMed,
000144748 7001_ $$0P:(DE-He78)75a948e2a369ddd0d4f3c1c07f833da3$$aJust, Alexandra$$b1$$udkfz
000144748 7001_ $$0P:(DE-He78)119d7d540a0e6fc5734898bef4866d7f$$aLeuchs, Barbara$$b2$$udkfz
000144748 7001_ $$0P:(DE-He78)2d7958ea507b0b738619074b38ec6d54$$aRommelaere, Jean$$b3$$udkfz
000144748 7001_ $$0P:(DE-He78)34bd069ab74ead9ac824c1e0896ecbf0$$aAngelova, Assia Ludmilova$$b4$$eLast author$$udkfz
000144748 773__ $$0PERI:(DE-600)2493551-7$$a10.1007/978-1-4939-9794-7_20$$p295-306$$tMethods in molecular biology$$v2058$$x1064-3745$$y2020
000144748 909CO $$ooai:inrepo02.dkfz.de:144748$$pVDB
000144748 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000144748 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)75a948e2a369ddd0d4f3c1c07f833da3$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000144748 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)119d7d540a0e6fc5734898bef4866d7f$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000144748 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2d7958ea507b0b738619074b38ec6d54$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000144748 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)34bd069ab74ead9ac824c1e0896ecbf0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000144748 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000144748 9141_ $$y2020
000144748 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144748 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144748 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144748 9202_ $$0I:(DE-He78)F010-20160331$$kF010$$lF010 Tumorvirologie$$x0
000144748 9201_ $$0I:(DE-He78)F010-20160331$$kF010$$lF010 Tumorvirologie$$x0
000144748 9200_ $$0I:(DE-He78)F010-20160331$$kF010$$lF010 Tumorvirologie$$x0
000144748 980__ $$ajournal
000144748 980__ $$aVDB
000144748 980__ $$abook
000144748 980__ $$aI:(DE-He78)F010-20160331
000144748 980__ $$aUNRESTRICTED